Frost.com - Pharmaceuticals and Biotechnology Researchhttp://www.frost.com/prod/servlet/svcg.pag/HCPD
http://www.frost.com/prod/servlet/svcg.pag/HCPD
- Pharmaceuticals and Biotechnology ResearchFrost & SullivanGenetic Technology Alert. Diagnostic Test Offers Risk Assessment for Graft Rejection; Genetic Variant Enhances Risk of Lung Cancer in Nonsmokers; Patient Specific Profiling For Cancer Treatmenthttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1F-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1F-00-00
This issue profiles a diagnostic test that offers risk assessment for graft rejection, a genetic variant that enhances risk of lung cancer in nonsmokers, and a patient-specific profiling for cancer treatment. Strategic partnership details and some important patents have also been included.Fri, 12 Mar 2010 04:42:40 +0000Nutrition Research Alert. Low-Fat Vegetarian Diet Enhances Macronutrient Acceptability in Diabetics; Effect of Iron-Fortified Rice on Iron Status in Young Children; Nonheme Iron Intake and Risk of Hypertensionhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D813-00-77-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D813-00-77-00-00
This issue profiles a low-fat vegetarian diet that enhances macronutrient acceptability in diabetics, effect of iron-fortified rice on iron status in young children, and effects of n-3 FAs supplementation on vascular functioning in type 2 diabetes mellitus.Fri, 5 Mar 2010 01:36:52 +0000Open & Collaborative Innovation in Life Science R&Dhttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=194667475
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=194667475
Frost & Sullivan is media partner for this event which will be looking at Open & Collaborative Innovation specifically in life sciences industry. Wed, 3 Mar 2010 00:00:00 +00003rd Annual Pharmaceutical Pricing & Reimbursement in Central & Eastern Europehttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=194667700
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=194667700
Frost & Sullivan is media partner for this event which will present the most updated and original perspectives on communicating the cost-effectiveness of high valued drugs to key stakeholders in the former communist countries of Central and Eastern Europe (CEE EU members, The Balkans, Russia and the former Soviet states).Wed, 3 Mar 2010 00:00:00 +0000Genetic Technology Alert. Noninvasive Test Checks for Kidney Transplant Rejection; Researchers Develop Strategy To Advance Cancer Vaccine; Viral Protein that Could Inhibit the Human Complement Systemhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1C-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1C-00-00
This issue profilesnoninvasive test checks for kidney transplant rejection, the development of a strategy to advance cancer vaccine, and a viral protein that could inhibit the human complement system. Strategic partnership details and some important patents have also been included.Fri, 19 Feb 2010 00:35:19 +0000Drug Discovery Technology Alert. Mushroom-Derived Cancer Drug; Repositioned Drugs for PAD Treatment; Magnetic Nanoparticles Show Promise for in vitro Capture and Isolation of Cancer Cellshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-23-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-23-00-00
This issue profiles mushroom-derived cancer drug, repositioned drugs for peripheral artery disease treatment, and magnetic nanoparticles that show promise for in vitro capture and isolation of cancer cells.Fri, 12 Feb 2010 06:18:20 +0000Genetic Technology Alert. Generating iPSC from Both Mouse and Human Cells; New Vaccine Technology against Allergy; Leukemia Treatment Using Umbilical Cord Cellhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1B-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-1B-00-00
This issue profiles generating iPSC from both mouse and human cells, a new vaccine technology for allergies, and using umbilical cord cells for leukemia treatment. Strategic partnership details and some important patents have also been included.Fri, 12 Feb 2010 00:31:37 +0000Cambridge Healthtech Institute's Second Annual - Combination Drug Therapieshttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=192141607
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=192141607
Cambridge Healthtech Institute's Second Annual - Combination Drug TherapiesTue, 9 Feb 2010 00:00:00 +0000Nutrition Research Alert. Western Style Diet and Colorectal Cancer; Obesity Indicators and Cardiometabolic Status in Preschool Children; Effect of Dietary Fiber on Body Weight and Waist Circumferencehttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D813-00-76-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D813-00-76-00-00
This issue profiles obesity indicators and cardiometabolic status in preschool children, effect of dietary fiber on body weight and waist circumference, and association between dietary protein intake and calcium metabolism.Fri, 5 Feb 2010 00:54:51 +0000Risk-Sharing & Value-Based Pricing Schemes http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=191320590
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=191320590
There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients. Wed, 3 Feb 2010 00:00:00 +0000Enhancing Performance of Early Phase Drug Developement Projectshttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=191365489
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=191365489
The pharmaceutical industry is constantly facing increasing demands for efficiency and cost effectiveness, making the development of project management skills and tools combined with their flawless application critical to deliver the best chance of success for a new compound. Wed, 3 Feb 2010 00:00:00 +0000Genetic Technology Alert. Improved HCV Therapy through New DNA-Based Technology; Cells Responsible for Childhood Leukemia Identified; New Insights into Brain Development and Functionhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-19-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-19-00-00
This issue profiles improved HCV therapy through new DNA-based technology, researchers identify cells responsible for childhood leukemia, and new insights into brain development and function. Strategic partnership details and some important patents have also been included.Fri, 29 Jan 2010 23:14:26 +0000Medical Devices Technology Alert. Linear Micro Motor for Medical Applications; Gastric Electrical Stimulation for Type 2 Diabetes; Endothelial Cells Engineered To Grow Blood Vesselshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D850-00-9D-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D850-00-9D-00-00
This issue profiles a a linear micro motor used for medical applications, gastric electrical stimulation for type 2 diabetes, and endothelial cells engineered to grow blood vessels.Fri, 29 Jan 2010 22:59:26 +0000